NPI registry status
Active
2026 NPPES data Infectious Disease Physician NPI 1538250808 M.D.
Verify on CMS → Daniel Boken, M.D.
Infectious Disease Physician in Visalia, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,537 in Infectious Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
831
Medicare Part D claims · 100 beneficiaries · Infectious Disease Physician avg: 807
Generic prescribing
43%
generic claims · 57% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$98.61
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Daniel Boken, M.D. filed 831 Medicare Part D claims in 2024 as an Infectious Disease Physician in Visalia, California, prescribing 43% generic.
- 831
- Part D claims, 2024
- 43%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥72nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Daniel Boken, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1538250808), first enumerated 09/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 831 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$98.61 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Daniel Boken, M.D.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1538250808 · Infectious Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1538250808
- ENUM-LEGACY 2006
- TAX-MID 9K Infectious Disease
- RX-LIGHT 831
- BOOK-LIGHT 899 in California
- PHOTO-ENUM John Ho · 2006
Daniel Boken, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
831 ≥ 72nd percentile 72% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Daniel Boken, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Boken, M.D.?
Quality data not reportedPrimary specialty
Infectious Disease Physician
Medicare Part D claims
831 3% vs specialty avg
Specialty distribution in California
How Infectious Disease Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Infectious Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1538250808 |
|---|---|
| Specialty | Infectious Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/28/2006 |
Hospital and facility affiliations
Facilities where Daniel Boken, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
County OF Tulare
Visalia, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Boken, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$99
Largest payer
Gilead Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Daniel Boken, M.D.. To verify Daniel Boken, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Daniel Boken, M.D. - brand share 57.0%
Infectious Disease Physician average
57% brand-name claims vs 43% generic, on 831 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
831
Total Claims
$1.8M
Total Drug Cost
100
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 901.6
- Total Day Supply
- 26,834
- Brand vs Generic
- 57% brand / 43% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $86K
- Antibiotic Claims
- 28
Patient Demographics
- Average Patient Age
- 65.9 years
- Avg HCC Risk Score
- 1.93
- Gender Split
- 29% female / 71% male
- Age Distribution
- <65: 31, 65-74: 46, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Daniel Boken, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluconazole
Fluconazole
142 claims
- Dovato
Dovato
130 claims
- Triumeq
Triumeq
76 claims
- Biktarvy
Biktarvy
71 claims
- Efavirenz-Emtric-T…
Efavirenz-Emtric-Tenofov Disop
68 claims
- Tivicay 42
Tivicay
42 claims
- Juluca 29
Juluca
29 claims
- Emtricitabine-Teno… 24
Emtricitabine-Tenofovir Disop
24 claims
| Drug | Claims |
|---|---|
| Fluconazole | 142 |
| Dovato Dolutegravir Sodium/Lamivudine | 130 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 76 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 71 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 68 |
| Tivicay Dolutegravir Sodium | 42 |
| Juluca Dolutegravir/Rilpivirine | 29 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 24 |
| Ritonavir | 24 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Infectious Disease Physician Overview
How Daniel Boken, M.D. fits within the Infectious Disease Physician landscape nationally.
8,537
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
807
Avg Claims per Provider
Daniel Boken, M.D.'s 831 claims are above the specialty average of 807.
Nationwide Infectious Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Boken, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Infectious Disease Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Boken.
One of 899 Infectious Disease Physician providers enrolled in California, 5 are shown here.
Dr. Sanaz Abderrahmane
M.D.
Sacramento, CA
Dr. Glen Abergel
M.D.
Oxnard, CA
Dr. Igor Abolnik
MD
Rureka, CA
Dr. Nehkonti Adams
M.D.
San Diego, CA
Dr. Alina Adeel
M.D
La Jolla, CA
Compare Infectious Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Daniel Boken, M.D.'s specialty? ▼
Daniel Boken, M.D. specializes in Infectious Disease Physician and practices in Visalia, California. Credentials: M.D..
How much does Daniel Boken, M.D. prescribe under Medicare Part D? ▼
In 2024, Daniel Boken, M.D. wrote 831 Medicare Part D claims totaling $1.8M in drug costs for 100 beneficiaries.
Where is Daniel Boken, M.D. located? ▼
Daniel Boken, M.D. is located at 116 N AKERS ST, Visalia, CA, 93291. Phone: (559) 624-2735.
What is Daniel Boken, M.D.'s NPI number? ▼
Daniel Boken, M.D.'s National Provider Identifier (NPI) is 1538250808, issued on 09/28/2006.
Does Daniel Boken, M.D. prescribe more brand-name or generic drugs? ▼
Daniel Boken, M.D.'s prescribing is 57% brand-name and 43% generic drugs by claim count, with $1.7M in brand drug costs.
How many Infectious Disease Physician providers are there in the US? ▼
There are 8,537 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 807 Medicare Part D claims per year.
What drugs does Daniel Boken, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Daniel Boken, M.D.'s most frequently prescribed drugs include Fluconazole, Dovato, Triumeq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Boken, M.D. accept Medicare? ▼
Daniel Boken, M.D. appears in CMS Medicare data with 831 Part D claims and 100 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Boken, M.D.'s credentials? ▼
Daniel Boken, M.D.'s NPI is 1538250808 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.